Caplin Point Laboratories has informed that it enclosed a Press Release regarding receipt of final approval by its Subsidiary Caplin Steriles from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Phytonadione Injectable Emulsion USP, 10 mg/mL, Single Dose Vial, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) VITAMIN K1 Injection, from Hospira Inc.
The above information is a part of company’s filings submitted to BSE.
